KPP Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Hold
2,175
0.03% 314
2026
Q1
$303K Sell
2,175
-75
-3% -$10.5K 0.04% 282
2025
Q4
$276K Buy
2,250
+15
+0.7% +$1.82K 0.04% 284
2025
Q3
$248K Sell
2,235
-30
-1% -$3.41K 0.04% 300
2025
Q2
$251K Sell
2,265
-14
-0.6% -$1.49K 0.04% 277
2025
Q1
$255K Sell
2,279
-179
-7% -$18.5K 0.05% 258
2024
Q4
$227K Sell
2,458
-2
-0.1% -$180 0.05% 230
2024
Q3
$206K Buy
+2,460
New +$188K 0.05% 246
2023
Q4
Sell
-2,949
Closed -$221K 157
2023
Q3
$221K Buy
+2,949
New +$227K 0.07% 187

Other funds holding GILD

KPP Advisory Services's GILD Position: Q2 2026 in Review

KPP Advisory Services held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,175 shares worth $275K. The position accounts for 0.03% of the portfolio, ranked #314.

KPP Advisory Services first reported a position in GILD in Q3 2023 and has held it in 9 quarters since. The position peaked at $303K in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • KPP Advisory Services held 2,175 shares of Gilead Sciences worth $275K as of Q2 2026.
  • KPP Advisory Services left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.03% of KPP Advisory Services's portfolio in Q2 2026, its #314 holding.
  • KPP Advisory Services first reported a position in Gilead Sciences in Q3 2023 and has held it in 9 quarters since.
  • KPP Advisory Services's Gilead Sciences position peaked at $303K in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.